CLINICAL_TRIALS trial_result · 2013-05-17

Clinical Trial Update: The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) [Phase 3]

Phase 3 trial evaluating canagliflozin as add-on therapy to a DPP-4 inhibitor for adults with type 2 diabetes; results were posted in May 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-05-17